Showing results (91-100 of 329) with videos related to
Sort By:
Pageof 33
Antimicrobial Agents and Chemotherapy|January 1, 1979
Mechanism of aminoglycoside antibiotic resistance in anaerobic bacteria: Clostridium perfringens and Bacteroides fragilisL E Bryan, S K Kowand, H M Van Den ElzenCanadian Journal of Microbiology|May 1, 1975
Further properties of P-2 R-factors of Pseudomonas aeruginosa and their relationship to other plasmid groupsM S Shahrabadi, L E Bryan, H M Van Den ElizenAnnals of Internal Medicine|December 1, 1984
Sporadic cases of hemorrhagic colitis associated with Escherichia coli O157:H7. Clinical, epidemiologic, and bacteriologic featuresC H Pai, R Gordon, H V Sims, et al.Antimicrobial Agents and Chemotherapy|August 1, 1974
Gentamicin resistance in Pseudomonas aeruginosa: R-factor-mediated resistanceL E Bryan, M S Shahrabadi, H M van den ElzenAntimicrobial Agents and Chemotherapy|September 1, 1973
Mechanisms and spectrum of streptomycin resistance in a natural population of Pseudomonas aeruginosaJ T Tseng, L E Bryan, H M Van den ElzenAntimicrobial Agents and Chemotherapy|January 1, 1972
Transferable drug resistance in Pseudomonas aeruginosaL E Bryan, H M Van Den Elzen, J T TsengAntimicrobial Agents and Chemotherapy|September 1, 1989
Contribution of permeability and sensitivity to inhibition of DNA synthesis in determining susceptibilities of Escherichia coli, Pseudomonas aeruginosa, and Alcaligenes faecalis to ciprofloxacinJ Bedard, S Chamberland, S Wong, et al.Journal of Bacteriology|February 1, 1988
Heterogeneity of lipopolysaccharides from Pseudomonas aeruginosa: analysis of lipopolysaccharide chain lengthM Rivera, L E Bryan, R E Hancock, et al.Antimicrobial Agents and Chemotherapy|October 1, 1984
Evidence for two distinct mechanisms of resistance to polymyxin B in Pseudomonas aeruginosaR A Moore, L Chan, R E HancockArchives of Virology. Supplementum|December 17, 2005
Species barriers in prion diseases--brief reviewR A Moore, I Vorberg, S A PriolaPageof 33